Apoptosis
Apoptosis, also known as programmed cell death, is rigorously controlled process of cell death that leads to phagocytosis of unwanted cell. It is triggered after sufficient cellular damage and activated through extrinsic or intrinsic pathways. The intrinsic pathway is mainly occurs via release of cytochrome c from the mitochondria and regulates mitochondrial outer membrane permeabilization by Bcl-2 family proteins. The extrinsic pathway is induced by ligand binding to death receptor, such as Fas, TNFαR, DR3, DR4, and DR5. Caspases then cleave target proteins and nuclear lamins to promote DNA degradation, resulting apoptotic cells undergo phagocytosis. In addition, p53 has the ability to activate intrinsic and extrinsic pathways of apoptosis by inducing transcription of several proteins like Puma, Bid, Bax, TRAIL-R2, and CD95.
Some Inhibitors of apoptosis proteins (IAPs), such as XIAP/BIRC4 and Bruce/BIRC6, can block casapse activity through direct binding, while other IAPs, such as cIAP1/BIRC2, cIAP2/BIRC3, act as ubiquitin ligases that target caspases for ubiquitin-mediated degradation. Apoptosis is essential for growth, development and aging in multicellular organisms. Any alterations or abnormalities occurring in apoptotic processes contribute to development of human diseases, including cancer.
-   A4216 ThalidomideTarget: Ubiquitin E3 LigasesSummary: Immunomodulatory agent,sedative drug,angiogenesis inhibitor A4216 ThalidomideTarget: Ubiquitin E3 LigasesSummary: Immunomodulatory agent,sedative drug,angiogenesis inhibitor
-   A4230 NSC 66811Summary: MDM2 inhibitor A4230 NSC 66811Summary: MDM2 inhibitor
-   A4203 Tenovin-1Target: Sir2-like Family Deacetylases (Sirtuins)|p53|p21Summary: SIRT2 inhibitor, activates p53 A4203 Tenovin-1Target: Sir2-like Family Deacetylases (Sirtuins)|p53|p21Summary: SIRT2 inhibitor, activates p53
-   A4199 Sabutoclax2 CitationTarget: Bcl-2|Mcl-1|Bfl-1Summary: pan-Bcl-2 inhibitor A4199 Sabutoclax2 CitationTarget: Bcl-2|Mcl-1|Bfl-1Summary: pan-Bcl-2 inhibitor
-   A1922 Z-VDVAD-FMKSummary: Caspase-2 inhibitor A1922 Z-VDVAD-FMKSummary: Caspase-2 inhibitor
-   A3327 CostunolideTarget: FPTase|TelomerasesSummary: Apoptosis inducer A3327 CostunolideTarget: FPTase|TelomerasesSummary: Apoptosis inducer
-   A8634 WEHI-539 hydrochloride1 CitationSummary: Bcl-xL inhibitor,high affinity and selective A8634 WEHI-539 hydrochloride1 CitationSummary: Bcl-xL inhibitor,high affinity and selective
-   C4733 SulforaphaneSummary: inducer of chemopreventative enzymes via Keap1-Nrf2 signaling C4733 SulforaphaneSummary: inducer of chemopreventative enzymes via Keap1-Nrf2 signaling
-   C7117 D-Pantothenate sodium C7117 D-Pantothenate sodium
-   B7731 Necrosulfonamide8 CitationTarget: Mixed lineage kinase domain-like protein (MLKL)Summary: Necroptosis inhibitor B7731 Necrosulfonamide8 CitationTarget: Mixed lineage kinase domain-like protein (MLKL)Summary: Necroptosis inhibitor

